Literature DB >> 16735089

Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.

Sanober A Amin1, Chiang-Ching Huang, Scott Reierstad, Zhihong Lin, Zarema Arbieva, Elizabeth Wiley, Hossain Saborian, Ben Haynes, Helen Cotterill, Mitch Dowsett, Serdar E Bulun.   

Abstract

Paracrine interactions between adipose fibroblasts and malignant epithelial cells are essential for structural and hormonal support of breast tumors. Factors derived from malignant epithelial cells inhibit adipogenic differentiation of fibroblasts and upregulate expression of aromatase, which stimulates estrogen synthesis and creates a localized, growth-stimulatory environment. Here, we characterized the gene expression profile of breast adipose fibroblasts in an in vitro model of malignancy to identify other paracrine interactions that support tumor growth. Primary breast adipose fibroblasts from cancer-free women were treated with conditioned media from malignant breast epithelial cells or normal breast epithelial cells, and differences in gene expression were identified by microarray. A total of 79 differentially regulated genes encoding cytokines, enzymes, angiogenic factors, cytoskeletal proteins, extra-cellular matrix remodeling proteins, signal transduction proteins and cell surface receptors were identified, and 6 of these were verified by real-time PCR. Among these, the expression of aldo-keto reductase family 1, member C3 (AKR1C3) was upregulated. AKR1C3 has multiple enzymatic properties, including conversion of estrone to estradiol and androstenedione to testosterone. Immunoreactive AKR1C3 was detected in epithelial and stromal components of benign lesions and ductal carcinomas in situ, and in 59.8% of epithelial and 69.6% of stromal cells in invasive breast carcinomas. AKR1C3 expression was significantly higher in myoepithelial cells surrounding the neoplastic epithelium of ductal carcinoma in situ compared with those surrounding benign epithelial lesions. Importantly, AKR1C3 and aromatase mRNA levels correlated positively in 61 malignant breast tumors (R=0.3967, p=0.00156). Malignant epithelial cell-conditioned medium significantly increased formation of testosterone and estradiol from androstenedione in breast adipose fibroblasts. In conclusion, malignant epithelial cell-derived factors significantly upregulate the enzymes AKR1C3 and aromatase that catalyze a series of complementary reactions to convert the circulating precursor androstenedione to biologically active estradiol in vitro in the stromal fibroblasts, and in vivo, in stromal component of breast tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735089     DOI: 10.1016/j.mce.2006.04.029

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice.

Authors:  Hong Zhao; Elizabeth K Pearson; David C Brooks; John S Coon; Dong Chen; Masashi Demura; Ming Zhang; Charles V Clevenger; Xia Xu; Timothy D Veenstra; Robert T Chatterton; Francesco J DeMayo; Serdar E Bulun
Journal:  Endocrinology       Date:  2012-04-16       Impact factor: 4.736

3.  Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.

Authors:  Daniela Spano; Roberta Russo; Vittorio Di Maso; Natalia Rosso; Luigi M Terracciano; Massimo Roncalli; Luigi Tornillo; Mario Capasso; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2009-12-21       Impact factor: 6.354

4.  Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer.

Authors:  Michael C Byrns; Ling Duan; Seon Hwa Lee; Ian A Blair; Trevor M Penning
Journal:  J Steroid Biochem Mol Biol       Date:  2009-12-28       Impact factor: 4.292

5.  Expression of estrogen-related gene markers in breast cancer tissue predicts aromatase inhibitor responsiveness.

Authors:  Irene Moy; Zhihong Lin; Alfred W Rademaker; Scott Reierstad; Seema A Khan; Serdar E Bulun
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.